Impact of MRI-based postimplant dosimetric assessment in prostate brachytherapy using contrast-enhanced T1-weighted images |
| |
Authors: | Toshio Ohashi Tetsuo Momma Shoji Yamashita Katsumi Nagatsuma Kunimitsu Kanai Kazuhito Kitagawa Shinichi Takahashi Takashi Hanada Atsunori Yorozu Naoyuki Shigematsu |
| |
Affiliation: | 1. Department of Radiology, Keio University School of Medicine, Tokyo, Japan;2. Department of Radiology, National Hospital Organization Saitama Hospital, Saitama, Japan;3. Department of Urology, National Hospital Organization Saitama Hospital, Saitama, Japan;4. Department of Radiology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan |
| |
Abstract: | ![]() PurposeTo compare contrast-enhanced T1-weighted (CE-T1WI) magnetic resonance imaging (MRI) with computed tomography (CT) for postimplant dosimetry and seed recognition in prostate brachytherapy.Methods and MaterialsA total of 245 patients who received 125I prostate brachytherapy with or without external beam radiotherapy were enrolled. For postimplant analysis, CT and MRI scans were obtained at 1 month after seed implantation. For MRI-based dosimetry, T2-weighted images were fused with the CE-T1WI; the prostate was delineated on the T2-weighted images, and the seed detection was performed manually on the CE-T1WI. In CT-based dosimetry, the seed detection was essentially performed automatically. The dosimetric results obtained by MRI-based and CT-based dosimetry were compared.ResultsThe mean prostate D90 (the minimum dose received by 90% of the prostate volume) estimated by MRI-based and CT-based dosimetry were 113% and 115%, respectively, with no significant difference. The mean prostate V100 (the percent volume of the postimplant prostate receiving 100% of the prescribed dose) estimated by MRI-based and CT-based dosimetry were 95.2% and 95.8%, respectively, again with no significant difference. The mean prostate V150 (the percent volume of the postimplant prostate receiving 150% of the prescribed dose) estimated by MRI-based and CT-based dosimetry were 52.8% and 57.0%, respectively (p < 0.01). In all of the 35 patients (14%) in whom the MRI-based V150 were at least 10% lower than the CT-based results, the seed detection by CT-based dosimetry was overestimated in highly seed-clustered areas or in the areas close to calcifications because of reconstruction artifacts in CT images.ConclusionsMRI-based dosimetry using CE-T1WI appears to be acceptable. Our results suggest that MRI-based dosimetry is a practical method for estimation of the higher dose distribution, especially if seeds are clustered together or when they are close to calcifications. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|